Comparing the effects of Botox and rTMS on reducing migraine symptoms

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251022067727N1

Enrollment

100

Registered

2025-11-26

Start date

2025-12-21

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: Botox injections of 500 units are performed over a period of 3 months at specific points on the head and neck according to standard FDA protocol. Intervention 2: In

Eligibility

Sex/Gender

All

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age 25 to 55 years Suffering from migraine

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Suffering from brain tumors Patients with metal implants in the head and neck Sensitivity to Botox

Design outcomes

Primary

Measure	Time frame
Change in the number of migraine attacks. Timepoint: Before treatment, one, three and six months after treatment. Method of measurement: Interview and taking a history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnoush Ghaneifar

Islamic Azad University

ghaneifarmehrnoosh@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026